RNS Number : 0057Z
EMIS Group PLC
20 January 2022
20 January 2022
EMIS Group plc
("EMIS Group" or "the Group")
Notice of results
"Positive outcome for the year slightly above the top end of
EMIS Group plc (AIM: EMIS.L), the UK leader in connected
healthcare software and systems, today announces a trading update
for the year ended 31 December 2021.
The Group has performed strongly in 2021, with both revenue and
adjusted operating profit ahead of 2020 and slightly above the top
end of consensus* for the year.
In EMIS Health, the Group's revenues reflected a more normalised
trading period compared to 2020, with a higher proportion of
non-hardware revenues than the comparative period last year.
Looking forward, we continue to invest in the Group's technology
roadmap with the potential for acceleration over the next couple of
In EMIS Enterprise , the Group continues to drive double digit
growth in the areas of patient-facing services, analytics and
pharmacy, and is proud to be supporting the NHS Covid-19
vaccination programme through its Pinnacle software.
Post year-end acquisition
Following the year-end, the Group completed the acquisition of
Edenbridge Healthcare Limited, a leading provider of business
intelligence tools for GP practices, federations and commissioners.
It will expand the Group's capabilities in the growing analytics
markets by providing real time insight to support GP practice
access, efficiency, transformation and workforce planning. EMIS
Group acquired the business for GBP4.0m in cash paid from the
Group's existing cash resources, with further cash consideration of
up to GBP6.0m payable on the attainment of certain performance
The Group has a strong balance sheet with net cash of GBP64.0m
as at 31 December 2021 (31 December 2020: GBP53.0m), and in
December 2021 successfully secured a replacement revolving credit
facility of up to GBP60.0m with Barclays and NatWest for an initial
three year period.
Notice of final results
The Group intends to announce its results for the year ended 31
December 2021 on Thursday 17 March 2022. There will be a webcast
presentation for analysts and investors on the day, which will also
be available on the Group's website; please contact email@example.com
for further information.
Andy Thorburn, Chief Executive Officer of EMIS Group, said:
"I am delighted to confirm another year of positive progress at
the top end of our expectations.
"Our business continues to build good momentum for the future,
with our technology investment programme, bolt on acquisitions such
as that announced today, and continued high quality
customer-focussed execution from our team."
For further information, contact:
EMIS Group plc Tel: 0330 024 1269
Andy Thorburn, CEO
Peter Southby, CFO
Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000
Joshua Hughes/Simon Willis/James Black
MHP Communications Tel: 020 3128 8567
Reg Hoare/James Bavister/Florence Mayo firstname.lastname@example.org
*Information for investors, including analyst consensus
forecasts, can be found on the Group's website at
Notes to Editors
EMIS Group is the UK leader in connected healthcare software and
systems. Its solutions are widely used across every major UK
healthcare setting. EMIS Group's aim is to join up healthcare
through innovative technology, helping to deliver better health
outcomes to the UK population, supporting longer and healthier
EMIS Group has two core business segments: EMIS Health and EMIS
EMIS Health is a supplier of innovative integrated care
technology to the NHS, including primary, community, acute and
EMIS Enterprise is focussed on growth in the
business-to-business technology sector within the healthcare
market, including management of medicines, partner businesses,
patient-facing services and analytics.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact email@example.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
(END) Dow Jones Newswires
January 20, 2022 02:00 ET (07:00 GMT)
Gráfica de Acción Histórica
De Abr 2022 a May 2022
Gráfica de Acción Histórica
De May 2021 a May 2022